They reported an 82.9% sensitivity and 90.5% specificity for CD47-targeted imaging of bladder cancer with their fluorescent imaging approach, suggesting its potential for improving cancer detection and enabling image-guided surgery. The gene discussed is CD47; the disease is urinary bladder cancer.